Skip to main content
. 2014 May 22;5:233. doi: 10.3389/fimmu.2014.00233

Figure 4.

Figure 4

MSC2360844 and MSC2364588 inhibit BCR-induced signaling and activation of CD19+ B cells in healthy donors and SLE patients. (A) Peripheral blood from healthy donors were collected in heparinized tubes and stimulated with anti-IgM for 5 min. Intracellular pAkt gated on CD19+ cells were analyzed by flow cytometry. (B) Peripheral blood from healthy donors were collected in heparinized tubes and stimulated with anti-IgM for 18 h. CD69 up-regulation on CD19+ cells were analyzed by flow cytometry. Mean fluorescent intensity (MFI) from basal and stimulated conditions without inhibitor were used as 100% of activity. Data shown are mean ± SEM and are representative for at least five healthy donors. (C) PBMCs from two SLE patients were stimulated with anti-IgM for 18 h. CD69 up-regulation on CD19+ cells were analyzed by flow cytometry. Mean fluorescent intensity (MFI) from basal and stimulated conditions without inhibitor were used as 100% of activity.